CSPC Pharmaceutical Group Limited
1093Pharmaceuticals
HK$8.04+0.88%As of Oct 29vs prior close
- Market cap
- $11.7B
- P/E (TTM)
- 10.5×
- P/E (FY1)
- 7.7×
- From 52W high
- −23.10%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥31.3B
- Net margin
- 23.71%
- Dividend yield
- 3.61%
Nomior Score
64
Steady ProfileTop 18% of the scored universe
Growth41
Quality68
Value59
Momentum73
Resilience54
Growth
−5.62%revenue a year over 3 fiscal years
YE22 CN¥30.9BLTM CN¥31.3B
Connections
Revenue to profitYE25
15% of revenue became net profit.